The Role of Clinical Features and Serum Biomarkers in Identifying Patients with Incomplete Lupus Erythematosus at Higher Risk of Transitioning to Systemic Lupus Erythematosus: Current Perspectives

Discovery of antinuclear antibodies (ANA) enabled earlier diagnosis of systemic lupus erythematosus (SLE) and other ANA(+) connective tissue diseases (CTD). Rheumatologists increasingly encounter high referral volume of ANA(+) patients. It has been estimated that only a small percentage of these pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Sternhagen, Erin, Bettendorf, Brittany, Lenert, Aleksander, Lenert, Petar S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863324/
https://www.ncbi.nlm.nih.gov/pubmed/35210816
http://dx.doi.org/10.2147/JIR.S275043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863324/
https://www.ncbi.nlm.nih.gov/pubmed/35210816
http://dx.doi.org/10.2147/JIR.S275043

Ejemplares similares